On November 5, 2020, Shenyang Dasan Pharmaceutical Technology Co., Ltd. held a video conference with Dasan Pharmaceutical Co., Ltd. and Shanghai Gaozhun Pharmaceutical.

Attendees:
Dasan Pharmaceutical: Kim Do-kyung (Managing Director), Kwon Man-ho (Head of Formulation Department), Kang (Head of Analysis Department), Lee (Head of Innovation Business Department), Song (Head of Formulation Department), Kim (Head of Planning Department);
Gaozhun Pharmaceutical: Liu Zhenhao (General Manager);
Shenyang Dasan: Yan Dong (General Manager), Han Xiao (Technical Director), Wang Xinyu (Administration and HR Manager), Lei Jiang (Analysis Manager), Li Bin (Registration Manager), Zhang Yu (Quality Manager), Nam Jung-sook (Interpreter).

During the meeting, both sides exchanged views on the following topics:
1. Relocation of Shenyang Dasan Pharmaceutical Technology Co., Ltd.'s laboratory
2. Equity changes of Shenyang Dasan Pharmaceutical Technology Co., Ltd.
3. Introduction of honors received by Shenyang Dasan Pharmaceutical Technology Co., Ltd.
4. Analysis of changes in the Chinese pharmaceutical market
5. Introduction of project progress at Shenyang Dasan Pharmaceutical Technology Co., Ltd.

This meeting was the first video conference since Shenyang Dasan and Korea Dasan established their joint venture. Through this meeting, both sides engaged in in-depth exchanges on company management and project progress, and agreed to hold regular video conferences in the future.